Skip to Content

'
Daniel Gomez

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2004 University of California, San Francisco, CA, MD, Medical School
1999 University of Virginia, Charlottesville, VA, BA, Economics

Postgraduate Training

7/2005-12/2008 Clinical Residency, Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY
7/2004-6/2005 Medicine Internship, St. Mary's Medical Center, San Francisco, CA

Board Certifications

6/2010 Radiation Oncology

Honors and Awards

2011-2012 Comparative Effectiveness Research on Cancer in Texas Scholar
2009-2011 Recipient, National Institutes of Health Loan Repayment Program
2009 Radiologic Society of North America Resident/Fellow Research Award
2002-2003 Doris Duke Clinical Research Fellowship Recipient
2001-2002 Gregory Scholarship Recipient
2001-2002 Mackenzie Scholarship Recipient
1999-present Duncan Clarke Hyde Award for Exceptional Academic Performance in Economics, Duncan Clarke
1999-2004 Bernard J. Osher Scholorship Recipient
1999 Graduated with Highest Distinction, University of Virginia
1998-1999 Distinguished Majors Program in Economics, University of Virginia
1995-1998 Undergraduate Scholarship Recipient, Lockheed Martin
1995 Valedictorian, Chatfield Senior High School

Selected Publications

Peer-Reviewed Original Research Articles
1. Lopez Guerra JL, Wei Q, Yuan X, Gomez D, Liu Z, Zhuang Y, Yin M, Li M, Wang LE, Cox JD, Liao Z. Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy. Radiother Oncol. e-Pub 9/19/2011. PMID: 21937138.
2. Gomez DR, Cox JD, Roth JA, Allen PK, Wei X, Mehran RJ, Kim JY, Swisher SG, Rice DC, Komaki R. A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumors. Cancer. e-Pub 6/28/2011. PMID: 21713767.
3. Yin M, Liao Z, Liu Z, Wang LE, O'Reilly M, Gomez D, Li M, Komaki R, Wei Q. Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy. Cancer. e-Pub 6/29/2011. PMID: 21717429.
4. Gomez DR, Estilo CL, Wolden SL, Zelefsky MJ, Kraus DH, Wong RJ, Shaha AR, Shah JP, Mechalakos JG, Lee NY. Correlation of Osteoradionecrosis and Dental Events with Dosimetric Parameters in Intensity-Modulated Radiation Therapy for Head-and-Neck Cancer. Int J Radiat Oncol Biol Phys. e-Pub 5/11/2011. PMID: 21570202.
5. Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, Zhu XR, Likhacheva A, Liao Z, Hofstetter WL, Ajani JA, Cox JD. Intensity-modulated proton therapy further reduces normal- tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study. Int J Radiat Oncol Biol Phys. e-Pub 4/4/2011. PMID: 21470796.
6. Chi A, Liao Z, Nguyen NP, Howe C, Gomez D, Jang SY, Komaki R. Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined-Modality Treatment of Malignant Pleural Mesothelioma. J Thorac Oncol. e-Pub 4/2011. PMID: 21532502.
7. Yin M, Liao Z, Liu Z, Wang LE, Gomez D, Komaki R, Wei Q. Functional Polymorphisms of Base Excision Repair Genes XRCC1 and APEX1 Predict Risk of Radiation Pneumonitis in Patients with Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy. Int J Radiat Oncol Biol Phys. e-Pub 3/17/2011. PMCID: PMC3136565.
8. Welsh J, Palmer MB, Ajani JA, Liao Z, Swisher SG, Hofstetter WL, Allen PK, Settle SH, Gomez D, Likhacheva A, Cox JD, Komaki R. Esophageal cancer dose escalation using a simultaneous integrated boost technique. Int J Radiat Oncol Biol Phys. e-Pub 11/29/2010. PMID: 21123005.
9. Wu AJ, Gomez J, Zhung JE, Chan K, Gomez DR, Wolden SL, Zelefsky MJ, Wolchok JD, Carvajal RD, Chapman PB, Wong RJ, Shaha AR, Kraus DH, Shah JP, Lee NY. Radiotherapy after surgical resection for head and neck mucosal melanoma. Am J Clin Oncol 33(3):281-5, 6/2010. PMID: 19823070.
10. Gomez D, Cahlon O, Mechalakos J, Lee N. An investigation of intensity-modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer. Radiat Oncol 5:74, 2010. e-Pub 8/26/2010. PMCID: PMC2940770.
11. Gomez DR, Hunt MA, Jackson A, O'Meara WP, Bukanova EN, Zelefsky MJ, Yamada Y, Rosenzweig KE. Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy. Radiother Oncol 93(3):414-8, 12/2009. e-Pub 11/16/2009. PMCID: PMC2858382.
12. Gomez DR, Katabi N, Zhung J, Wolden SL, Zelefsky MJ, Kraus DH, Shah JP, Wong RJ, Ghossein RA, Lee NY. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer 115(10):2128-37, 5/2009. PMID: 19309749.
13. Gomez DR, Zhung JE, Gomez J, Chan K, Wu AJ, Wolden SL, Pfister DG, Shaha A, Shah JP, Kraus DH, Wong RJ, Lee NY. Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys 73(4). e-Pub 8/15/2008. PMID: 18707827.
14. Rivera M, Ghossein RA, Schoder H, Gomez D, Larson SM, Tuttle RM. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma. Cancer 113(1):48-56, 7/1/2008. PMID: 18484584.
15. Gomez DR, Hoppe BS, Wolden SL, Zhung JE, Patel SG, Kraus DH, Shah JP, Ghossein RA, Lee NY. Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience. Int J Radiat Oncol Biol Phys 70(5):1365-72, 4/1/2008. e-Pub 10/29/2007. PMID: 18029108.
16. Hoppe BS, Nelson CJ, Gomez DR, Stegman LD, Wu AJ, Wolden SL, Pfister DG, Zelefsky MJ, Shah JP, Kraus DH, Lee NY. Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. Int J Radiat Oncol Biol Phys 72(3). e-Pub 4/18/2008. PMID: 18395361.
17. Gomez DR, Missett BT, Wara WM, Lamborn KR, Prados MD, Chang S, Berger MS, Haas-Kogan DA. High failure rate in spinal ependymomas with long-term follow-up. Neuro Oncol 7(3):254-9, 7/2005. PMCID: PMC1871913.

Invited Articles
1. Gomez D, Komaki R, Yu J, Ikushima H, Bezjak A. Radiation Therapy Definitions and Reporting Guidelines for Thymic Malignancies. J Thorac Oncol 6(7 Suppl 3):S1743-S1748, 7/2011. PMID: 21847057.
2. Welsh J, Amini A, Likhacheva A, Erasmus J J, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL, Lee H J, Bhutani MS, Ajani JA. Modern Approaches to the Treatment of Localized Esophageal Cancer. Curr Oncol Rep 13(3):67, 6/2011. PMID: 21365188.
3. Gomez DR, Chang JY. Adaptive Radiation for Lung Cancer. J Oncol 2011, 2011. e-Pub 8/4/2010. PMCID: PMC2931378.
4. Gomez D, Komaki R. Technical advances of radiation therapy for thymic malignancies. J Thorac Oncol 5(10 Suppl 4):S336-43, 10/2010. e-Pub 10/2010. PMID: 20859129.

Book Chapters
1. Gomez D, Fuller C, Chennupati S, Thomas C. Mediastinal and Tracheal Tumors. In: Principles and Practices of Radiation Oncology, 6th. Lippincott Williams and Wilkins, 2012.
2. Gomez D, Jeter M, Komaki R, Cox J. Radiation Time, Dose and Fractionation in the Treatment of Lung Cancer. In: Advances in Radiation Oncology of Lung Cancer, 2nd. Springer Verlag Publishers, 2012.
3. Gomez D, Liao Z. Radiation Toxicity in the Treatment of Lung Cancer with 3D-Conformal Therapy, Intensity Modulated Radiation Therapy, and Proton Beam Therapy. In: Radiation Therapy: Types, Procedures and Outcomes. Nova Science Publishers, 2012.
4. Troung MT, Gomez D, Chang JY, Mehran RJ. Oncologic imaging for the practicing radiologist. In: Medical Oncologist and Surgeon. Elsevier Publishing, 2011.
5. Gomez D, Lee N. Oral Cavity Cancer. In: Textbook of Radiation Oncology. WB Saunders Publishing, 2009.
6. Gomez D, Chao K, Lee N. Target Delineation in Head and Neck Cancer. In: Image Guided and Adaptive Radiotherapy. Lippincott Williams & Wilkins Publishing, 2009.

Last updated: 1/10/2012